DB05971InvestigationalSmall molecule
Investigated for use/treatment in solid tumors.
- Mechanism
- Curator reviewed
RX-0201 is a first-in-class signal inhibitor that directly represses the production of Akt, a protein kinase that plays a key role in cancer progression. A less toxic therapeutic approach to cancer treatment, RX-0201 blocks the growth of tumor cells and promotes cell death (apoptosis).
- Primary indication
- Investigated for use/treatment in solid tumors.Curator reviewed
- Also known as
- 20-mer complementary to Akt mRNA · 5'-DG-DC-T-DG-DC-DA-T-DG-DA-T-DC-T-DC-DC-T-T-DG-DG-DC-DG-3' · 5'-DG-DC-T-DG-DC-DA-T-DG-DA-T-DC-T-DC-DC-T-T-DG-DG-DC-DG-3', SODIUM PHOSPHOTHIOATE
- Code names
- RX-0201 · RX-201 · WGI-0201
Resolves to
Compound
Targets
What you can answer from here — as of July 18, 2023
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Archexin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account